Diamyd Medical raises SEK 58.4 million through redemption of warrants

Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...

December 6, 2018 | Thursday | News
EC Approves Takeda’s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...

November 28, 2018 | Wednesday | News
HitGen, Biogen initiate drug discovery collaboration

HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identi...

November 22, 2018 | Thursday | News
World’s first migraine-specific prevention treatment available in Singapore

Singapore – Novartis announced that the Health Sciences Authority (HSA) has approved Aimovig (erenumab) ...

November 22, 2018 | Thursday | News
OBI Pharma granted FDA ODD for OBI-888

OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) h...

November 21, 2018 | Wednesday | News
Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities

Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...

November 15, 2018 | Thursday | News
MEI Pharma, KHK to develop and commercialize ME-401

MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...

November 5, 2018 | Monday | News
FDA OKs J&J's Invokana for heart conditions

Singapore –  The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...

October 31, 2018 | Wednesday | News
Halozyme licenses $25M drug delivery technology to Roche

Singapore – Halozyme has out-licensed its ENHANZE drug delivery technology to Roche for the exclusi...

October 30, 2018 | Tuesday | News
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain

Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...

October 24, 2018 | Wednesday | News
FDA approves Regeneron, Sanofi's Dupixent for asthma treatment

Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...

October 22, 2018 | Monday | News
Roche's Tecentriq extends progression-free survival in TNBC

Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...

October 22, 2018 | Monday | News
Ostrich antibody as dengue fever solution ready for commercialization

Singapore - MAZ World and ZEAL Cosmetics have confirmed that Ostrich Antibodies are effective in neutralising all four s...

October 22, 2018 | Monday | News
Strides Pharma gets USFDA nod for its anti-epileptic drug

Strides Pharma Science (Strides) on Saturday announced that its global arm Strides Pharma Global Pte Singapore has recei...

October 22, 2018 | Monday | News
Eisai discovers new compound to treat Parkinson's disease

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...

October 19, 2018 | Friday | News
Axsome receives FDA Orphan Drug designation for narcolepsy drug

Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...

October 17, 2018 | Wednesday | News
FDA issues new guidance for developers of complex generics

 Singapore - The FDA has released new guidance documents aimed at advancing development of generic versio...

October 10, 2018 | Wednesday | News
Novartis’ crizanlizumab relieves patients from sickle cell pain crisis

Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal ...

October 10, 2018 | Wednesday | News